Document Detail


Comparative effects of captopril and l-carnitine on blood pressure and antioxidant enzyme gene expression in the heart of spontaneously hypertensive rats.
MedLine Citation:
PMID:  20123095     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has been shown that oxidative stress is involved in the pathogenesis of arterial hypertension. The aim of this work was to study and compare the molecular mechanisms of the antioxidant properties of l-carnitine and captopril in spontaneously hypertensive rats (SHR). Antioxidant enzyme activity/regulation (glutathione peroxidase, glutathione reductase and superoxide dismutase) was measured in the erythrocytes and hearts of SHR. The molecular expression of endothelial nitric oxide synthase (eNOS), NADPH oxidase, angiotensin converting enzyme (ACE), angiotensin II type I receptor (AT(1) receptor) and NF-kappaB/IkappaB system was also measured in the hearts of these animals. Both l-carnitine and captopril augmented the antioxidant defense capacity in SHRs. This effect was mediated by an upregulation of antioxidant enzymes, an increase in the plasma total antioxidant capacity and a reduction of lipid peroxidation and superoxide anion production in the heart. The administration of both compounds to hypertensive animals also produced an upregulation of eNOS and a normalization of ACE, angiotensin AT(1) receptor, and the NF-kappaB/IkappaB system expression. In addition, captopril reduced the arterial blood pressure and the relative heart weights back to control values, whereas l-carnitine caused only a partial reduction of blood pressure values and did not alter the cardiac hypertrophy found in SHRs. In conclusion, we have found that l-carnitine and captopril have a similar antioxidant effect in the hearts of hypertensive rats. The molecular regulation of antioxidant enzymes through an inhibition of the renin-angiotensin system and a modulation of the NF-kappaB/IkappaB system seems to be responsible for this antioxidant effect.
Authors:
Jos? L Miguel-Carrasco; Mar?a T Monserrat; Alfonso Mate; Carmen M V?zquez
Related Documents :
6263205 - Serial observations of angiotensin-converting enzyme and pulmonary function in sarcoido...
2161435 - Ace inhibition and pressor responsiveness to norepinephrine in hypertensive patients.
8313395 - Clinical pharmacology of reversible monoamine oxidase-a inhibitors.
7528985 - Dissociation between antiproteinuric and antihypertensive effect of angiotensin convert...
23717285 - Angiotensin-ii-derived reactive oxygen species on baroreflex sensitivity during hyperte...
16770925 - Nonpharmacologic strategies for managing hypertension.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-01
Journal Detail:
Title:  European journal of pharmacology     Volume:  632     ISSN:  1879-0712     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-08     Completed Date:  2010-07-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  65-72     Citation Subset:  IM    
Copyright Information:
2010 Elsevier B.V. All rights reserved.
Affiliation:
Departamento de Fisiolog?a y Zoolog?a, Universidad de Sevilla, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects*
Captopril / pharmacology*
Carnitine / pharmacology*
Glutathione Peroxidase / metabolism*
Glutathione Reductase / metabolism*
Male
Rats
Rats, Inbred SHR
Superoxide Dismutase / metabolism*
Chemical
Reg. No./Substance:
541-15-1/Carnitine; 62571-86-2/Captopril; EC 1.11.1.9/Glutathione Peroxidase; EC 1.15.1.1/Superoxide Dismutase; EC 1.8.1.7/Glutathione Reductase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sonic hedgehog is required for vascular outgrowth in the hindbrain choroid plexus.
Next Document:  Protection in rats with heatstroke: Hyperbaric oxygen vs activated protein C therapy.